Brief: Autonomix Medical announces inducement grant under Nasdaq listing rule 5635(C)(4)
Brief: Autonomix Medical Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: Autonomix Medical Finalizes Design Of ASIC Microchip For Sensing Technology Catheter For Use In Humans
Brief: CVI Investments Reports 9.9% Passive Stake In Autonomix Medical As Of Nov 22
Brief: Autonomix Medical Announces Closing Of $10.0 Mln Underwritten Public Offering Including Partial Exercise Of Over-Allotment Option
U.S. STOCKS ON THE MOVE-CC Holding, CBRE, Lexicon Pharmaceuticals
Autonomix Medical slumps after $9 mln stock offering
Brief: Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means From Lead-In Patients In Ongoing Human Clinical Trial
U.S. STOCKS ON THE MOVE-Monte Rosa, EyePoint Pharma, Shake Shack
Autonomix jumps after its treatment reduces pain during trial
Brief: Positive Preliminary Results Demonstrate Autonomix’S Proprietary RF Ablation Technology’S Ability To Reduce Opioid Use In Ongoing Human Clinical Trial
Brief: Autonomix Announces Reverse Stock Split
Brief: Biostar Ventures Reports 10.5% Passive Stake In Autonomix Medical As Of June 30
Brief: Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations
Brief: Autonomix Announces Positive Topline Results From First Five Lead-In Patients In Ongoing Human Clinical Trial
Brief: Autonomix Enhances Executive Leadership Team With Appointment Of Proven Medical Technology Leader, Brad Hauser, As President And Chief Executive Officer
Brief: Autonomix Enters Into Agreement With NoiseFigure Research To Develop Next Generation Of Its Proprietary Microchip
Brief: Autonomix Announces Issuance Of US Patent Covering Proprietary Catheter-Based Technology For The Treatment Of Cancer Related Pain
Brief: Autonomix Enrolls First Patients In Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market